The race for artificial intelligence is one of the biggest gold mines in the global economy and the technology sector. The development of better models can spur growth in unrelated areas that most investors haven't seen coming.

SAN DIEGO, July 14, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between April 29, 2025 and June 23, 2025, both dates inclusive (the “Class Period”), have until Monday, August 25, 2025 to seek appointment as lead plaintiff of the Hims & Hers class action lawsuit. Captioned Sookdeo v. Hims & Hers Health, Inc., No. 25-cv-05315 (N.D. Cal.), the Hims & Hers class action lawsuit charges Hims & Hers as well as certain of Hims & Hers' top executives with violations of the Securities …

I focus on dividend investing to build a reliable income stream, prioritizing companies with strong fundamentals and consistent dividend growth. Old Republic International stands out for its robust earnings, special dividends, and over 40 years of dividend increases, trading at an attractive valuation. Ares Capital offers a high yield, strong liquidity, and a history of stable dividends, making it a solid choice for income-focused investors.

Airline begins adding new destinations to its network for the first time since 2021 DALLAS , July 14, 2025 /PRNewswire/ -- Southwest Airlines Co. (NYSE: LUV) intends to grow its network in 2026 initially with new service at Cyril E. King International Airport (STT) on St. Thomas, adding the U.S. Virgin Islands to the carrier's tropical destinations in the Caribbean.

For most investors, especially beginners, I recommend avoiding individual stock picking and instead investing in broad market ETFs. SPY and VTI both offer diversified, low-cost exposure to the US stock market, but SPY's concentration in blue-chip firms has led to better returns and lower drawdowns. VTI includes mid- and small-caps, which can boost returns in early bull markets but also increase volatility and downside risk during downturns.

WIT, KNOP, PENG, ELDN and KDDIY have been added to the Zacks Rank #1 (Strong Buy) List on July 14, 2025.

For years now, UnitedHealth Group has been the first of the major health insurers to report its quarterly earnings. And Wall Street analysts and investors have looked to the healthcare giant -- which owns the nation's largest health insurer – for clues on how the sector is doing.

MINNEAPOLIS, July 14, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the issuance of U.S. Patent No. 12,350,276 covering the clinical dosing regimen for its lead drug candidate, gedatolisib, in ER+/HER2- breast cancer patients. The patent extends Celcuity's patent exclusivity in the U.S. into 2042.

RICHMOND, Va., July 14, 2025 (GLOBE NEWSWIRE) -- The board of directors of The Brink's Company (NYSE:BCO), on July 11, 2025, declared a regular quarterly dividend of $0.255 per share on the company's common stock. The dividend is payable on September 2, 2025, to shareholders of record on July 28, 2025.

APEMY, CAR and BIDU have been added to the Zacks Rank #5 (Strong Sell) List on July 14, 2025.

ALBUQUERQUE, N.M. & MONTREAL & STØVRING, Denmark & WASHINGTON--(BUSINESS WIRE)-- #ANG--AIRO (Nasdaq: AIRO), a global leader in advanced aerospace and defense technologies, today announced plans to expand its U.S. footprint with the addition of a new manufacturing and engineering development facility. This strategic move builds on the success of AIRO's existing operations and is driven by the growing global demand for AIRO's flagship product, the RQ-35 ISR Drone. The RQ-35 ISR Drone has rapidly gained.

New U.S.-based role to support growth strategy, partnerships, and scaling of rhCollagen product platforms REHOVOT, Israel , July 14, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing disruptive technologies and products based on its non-animal-derived recombinant human collagen (rhCollagen), today announced the appointment of Bowman Bagley as Vice President, Commercial North America. In this newly created role, Mr.

FRIENDSWOOD, Texas, July 14, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the second quarter ended June 30, 2025, after the close of market on Monday, Aug. 4, 2025. Company management will host a conference call and webcast to discuss its financial results at 4:30 p.m.

LEXINGTON, S.C. and SANDY SPRINGS, Ga.

64 Valvoline Instant Oil Change℠ locations in New England are participating in "A Chance for Kids & Families®" program for the 12th consecutive year to raise money for Dana-Farberand the Jimmy Fund BOSTON , July 14, 2025 /PRNewswire/ -- Valvoline Instant Oil Change (VIOC) locations throughout New England are helping Dana-Farber Cancer Institute and the Jimmy Fund to defy cancer this summer through their participation in the "A Chance for Kids & Families®" program. Customers are invited to donate $1, $5, or $10 at a participating Valvoline Instant Oil Change location between July 13 and August 2 to do their …

CAMBRIDGE, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced the company will host a conference call and live webcast on Thursday, July 31, 2025, at 8:00 a.m.

MINNEAPOLIS , July 14, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that its Simple Western™ Technology played a key role in supporting the FDA approval of ZEVASKYN™ (prademagene zamikeracel), the first autologous cell-based gene therapy for patients with recessive dystrophic epidermolysis bullosa (RDEB), developed by Abeona Therapeutics® (NASDAQ: ABEO). Throughout clinical development, Simple Western enabled precise identification and quantification of Collagen VII, a complex therapeutic target critical to ZEVASKYN's potency, supporting lot release testing for the viral vector and the cell therapy in a GMP setting.

NORTHBROOK, Ill. , July 14, 2025 /PRNewswire/ -- Stepan Company (NYSE: SCL) announced today the appointment of Ruben Velasquez as Vice President and Chief Financial Officer of Stepan, effective as of July 15, 2025.

HAUPPAUGE, N.Y., July 14, 2025 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent company of Dime Community Bank (the “Bank”), announced today that Jason Brenner and Zack Schwartz were named Co-Heads of a newly established Lender Finance vertical.

Adding a fourth certified facility within its global network increases operational capacity to better serve international medical markets NASDAQ | TSX: ACB EDMONTON, AB , July 14, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce that its dedicated distribution centre located in Brampton, Ontario, has received European Union Good Manufacturing Practice ("EU-GMP") certification, increasing the company's international export capabilities. The distribution centre joins Aurora's group of manufacturing facilities in Canada and Europe certified against EU standards, demonstrating the company's unwavering commitment to regulatory excellence, end-to-end operational quality …